Article Dans Une Revue Anaesthesia Critical Care & Pain Medicine Année : 2024

Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network

1 HEGP - Hôpital Européen Georges Pompidou [APHP]
2 IThEM - U1140 - Innovations thérapeutiques en hémostase = Innovative Therapies in Haemostasis
3 HITH - U1176 Inserm - CHU Bicêtre - Hémostase, Inflammation, Thrombose
4 Hôpital Necker - Enfants Malades [AP-HP]
5 Innovte - F-Crin INvestigation Network On Venous Thrombo-Embolism [CHU Saint-Etienne]
6 CHUGA - Centre Hospitalier Universitaire [CHU Grenoble]
7 UGA - Université Grenoble Alpes
8 CHUM - Centre Hospitalier de l'Université de Montréal
9 HUG - Hôpitaux Universitaires de Genève
10 CHU Toulouse - Centre Hospitalier Universitaire de Toulouse
11 UPS/Inserm U1297 - I2MC - Institut des Maladies Métaboliques et Casdiovasculaires
12 CHU Tenon [AP-HP]
13 CHU Dijon
14 HUG - Geneva University Hospital
15 University of Toronto
16 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
17 Irset - Institut de recherche en santé, environnement et travail
18 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
19 HDF - Hôtel-Dieu de France
20 SAINBIOSE - Santé Ingénierie Biologie Saint-Etienne
21 Faculté de Médecine [Nancy]
22 FHU PROMICE - Fédération Hospitalo-Universitaire PRecision medicine for cOMprehensIve care of Critically ill patiEnts
23 LVTS (UMR_S_1148 / U1148) - Laboratoire de Recherche Vasculaire Translationnelle
24 AP-HP - Hôpital Bichat - Claude Bernard [Paris]
25 Duke University [Durham]
26 University of Ottawa [Ottawa]
27 ISCHEMIA - Membrane Signalling and Inflammation in reperfusion Injuries
28 OPTeN (UMR_S 1144 / U1144) - Optimisation thérapeutique en Neuropsychopharmacologie
29 C2VN - Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research
30 ULB - Université libre de Bruxelles
31 UCL - Université Catholique de Louvain = Catholic University of Louvain
32 URCA - Université de Reims Champagne-Ardenne
33 MITOVASC - MitoVasc - Physiopathologie Cardiovasculaire et Mitochondriale
34 UM - Université de Montpellier
35 CHU Amiens-Picardie
36 CHIMERE - CHirurgie, IMagerie et REgénération tissulaire de l’extrémité céphalique - Caractérisation morphologique et fonctionnelle - UR UPJV 7516
37 RNMCD - Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011
38 BPPS - Biologie et Pharmacologie des Plaquettes sanguines : hémostase, thrombose, transfusion
39 LBTO - Biologie Intégrative du Tissu Osseux
Ariel Cohen
  • Fonction : Auteur
Emmanuel de Maistre
  • Fonction : Auteur
Nadia Rosencher
  • Fonction : Auteur
Pierre Sié
  • Fonction : Auteur

Résumé

Background Any surgical procedure carries a risk for venous thromboembolism (VTE), albeit variable. Improvements in medical and surgical practices and the shortening of care pathways due to the development of day surgery and enhanced recovery after surgery, have reduced the perioperative risk for VTE. Objective A collaborative working group of experts in perioperative haemostasis updated in 2024 the recommendations for the Prevention of perioperative venous thromboembolism published in 2011. Methods The addressed questions were defined by 40 experts (GIHP, SFAR, SFTH and SFMV) and formulated in a PICO format. They performed the literature review and formulated recommendations according to the Grading of GRADE system. Recommendations were then validated by a vote determining the strength of each recommendation. Of note, these recommendations do not cover all surgical specialties. Especially, thromboprophylaxis in cardiac surgery, neurosurgery and obstetrics is not addressed. Results 78 recommendations were formalized into 17 sections, including patient-related VTE risk factors, types of surgery, extreme body weight, renal impairment, mechanical prophylaxis, distal deep vein thrombosis; 27 were found to have a high level of evidence (GRADE 1) and 41 a low level of evidence (GRADE 2) and 10 were expert opinion. All had strong agreement among the experts. Conclusions These guidelines help to weigh the perioperative risk for VTE (which includes the risk associated to surgery and the patient-related risk) against the adverse effects of thromboprophylaxis, either pharmacological or mechanical. This includes particularly the bleeding risk induced by antithrombotic drugs as well as costs.
Fichier non déposé

Dates et versions

hal-04753456 , version 1 (25-10-2024)

Licence

Identifiants

Citer

Anne Godier, Dominique Lasne, Gilles Pernod, Normand Blais, Fanny Bonhomme, et al.. Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network. Anaesthesia Critical Care & Pain Medicine, 2024, pp.101446. ⟨10.1016/j.accpm.2024.101446⟩. ⟨hal-04753456⟩
56 Consultations
0 Téléchargements

Altmetric

Partager

More